tirzepatide body composition Tirzepatide‐induced changes: Implications from the SURPASS‐3 MRI substudy The Effect of Tirzepatide on

The proportion of patients suffering from severe migraine disability fell from 61% to 30% in the active-treatment group (p=0.01) and from 54% to 47% in the placebo group (not significant)

doi: 10.1371/journal.pone.0220506

Suspected adverse reactions to any substance should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk

Individuals with obesity face a markedly increased risk of comorbidities such as dyslipidaemia, T2D, hypertension, coronary heart disease, stroke, gallbladder disease, respiratory disorders, sleep apnoea, osteoarthritis, and certain types of cancer [142]

This dead volume, typically 0.02 to 0.07 mL depending on the syringe, means you lose a small amount of solution with each draw